Literature DB >> 8465408

Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh.

A Hall1, Q Nahar.   

Abstract

Albendazole, a broad spectrum anthelmintic recently shown to be active in vitro against Giardia duodenalis, was given at 4 different dosages and compared with metronidazole in the treatment of children in Bangladesh infected with Giardia. Three stools were collected over 10 d after treatment and examined microscopically. Albendazole was found to be effective: single doses of either 600 mg (n = 103) or 800 mg (n = 114) successfully treated 62% and 75% of infections, respectively; 400 mg given either once a day for 3 d (n = 116) or for 5 d (n = 115) successfully treated 81% and 95% of all infections, respectively. Albendazole given daily at 400 mg for 5 d was as effective as metronidazole, which cured 97% of infections (n = 230). Albendazole may thus be an alternative treatment for infections with Giardia, while the moderate efficacy of single doses may provide a benefit in addition to its effects on several species of intestinal helminths.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465408     DOI: 10.1016/0035-9203(93)90435-s

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  20 in total

1.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Biology of Giardia lamblia.

Authors:  R D Adam
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 3.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 4.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 5.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

6.  Changes in beta-giardin sequence of Giardia intestinalis sensitive and resistant to albendazole strains.

Authors:  Enedina Jiménez-Cardoso; Leticia Eligio-García; Adrián Cortés-Campos; Andrés Flores-Luna; Pedro Valencia-Mayoral; Irma Lozada-Chávez
Journal:  Parasitol Res       Date:  2009-02-13       Impact factor: 2.289

7.  A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.

Authors:  Shahram Solaymani-Mohammadi; Jeanine M Genkinger; Christopher A Loffredo; Steven M Singer
Journal:  PLoS Negl Trop Dis       Date:  2010-05-11

Review 8.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Giardia lamblia: a report of drug effects under cell differentiation.

Authors:  Moema A Hausen; Richard Pereira de Oliveira; Ana Paula Rocha Gadelha; Loraine Campanati; Jorge José de Carvalho; Laís de Carvalho; Helene Santos Barbosa
Journal:  Parasitol Res       Date:  2009-05-12       Impact factor: 2.289

10.  A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children.

Authors:  A K Dutta; M A Phadke; A C Bagade; V Joshi; A Gazder; T K Biswas; H H Gill; S C Jagota
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.